Kapral Moira K, Laupacis Andreas, Phillips Stephen J, Silver Frank L, Hill Michael D, Fang Jiming, Richards Janice, Tu Jack V
Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Stroke. 2004 Jul;35(7):1756-62. doi: 10.1161/01.STR.0000130423.50191.9f. Epub 2004 May 13.
Guidelines and performance indicators have been established for acute stroke care. However, little is known about the process of stroke care delivery in Canada.
The Registry of the Canadian Stroke Network (RCSN) captured detailed clinical data on patients with stroke and transient ischemic attack seen at 21 acute care institutions across Canada. Data from phase 1 of the RCSN (June 2001 to February 2002) were used to determine the use of evidence-based acute stroke care interventions in participating institutions.
Overall, 4439 patients were seen during the study time frame and 1701 (38%) consented to full data collection. Thirty-one percent received care on a stroke unit or from a mobile stroke team. Among patients with ischemic stroke, 7% received thrombolysis, 80% underwent carotid imaging, 89% received antithrombotic agents, and 54% of those with atrial fibrillation received warfarin. There were significant intersite variations in the delivery of all of these interventions except for the use of antithrombotic agents, and these persisted after adjustment for age, sex, stroke type, and other comorbid conditions.
Patients in institutions participating in the RCSN received high-quality stroke care based on a number of performance measures. However, gaps exist in the provision of other elements of stroke care, particularly organized inpatient stroke care and warfarin for atrial fibrillation. Future research should explore explanations for these findings and focus on solutions to deficiencies in care.
急性卒中护理的指南和绩效指标已经确立。然而,对于加拿大卒中护理的实施过程却知之甚少。
加拿大卒中网络登记处(RCSN)收集了加拿大21家急症护理机构中卒中及短暂性脑缺血发作患者的详细临床数据。RCSN第一阶段(2001年6月至2002年2月)的数据用于确定参与机构中基于证据的急性卒中护理干预措施的使用情况。
总体而言,在研究时间段内共诊治了4439例患者,其中1701例(38%)同意进行完整的数据收集。31%的患者在卒中单元接受护理或由移动卒中团队提供护理。在缺血性卒中患者中,7%接受了溶栓治疗,80%接受了颈动脉成像检查,89%接受了抗血栓药物治疗,房颤患者中有54%接受了华法林治疗。除抗血栓药物的使用外,所有这些干预措施的实施在各机构间均存在显著差异,且在对年龄、性别、卒中类型及其他合并症进行调整后这些差异依然存在。
参与RCSN的机构中的患者在多项绩效指标方面接受了高质量的卒中护理。然而,在卒中护理的其他方面,尤其是有组织的住院卒中护理以及房颤患者的华法林治疗方面仍存在差距。未来的研究应探究这些发现的原因,并专注于解决护理缺陷的方法。